Sort
16,300 grants matching “fatty liver disease”
PNPLA3 in Susceptibility and Resistance to Fatty Liver Disease
$552,559Helen H. Hobbs · Ut Southwestern Medical Center · R01 · FY2024 · DK
Animal and plant proteins and glucose metabolism
$552,499Bettina Mittendorfer · Washington University · R01 · FY2019 · DK
Gene-by-diet interactions in metabolic syndrome traits
$552,396Aldons Jake Lusis · University Of California Los Angeles · P01 · FY2015 · HL
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study
$552,182Timothy Ross Morgan · Southern California Inst For Res/Educ · U01 · FY2012 · AA
Alterations in Post-Receptor Insulin Signaling in Diabetes and Insulin Resistance
$552,110C Ronald Kahn · Joslin Diabetes Center · R01 · FY2021 · DK
Exploring the Fetal Origins Hypothesis in Diverse Youth
$552,056Dana Dabelea · University Of Colorado Denver · R01 · FY2014 · DK
Bile acids and insulin sensitivity
$551,959Rebecca Anne Haeusler · Columbia University Health Sciences · R01 · FY2019 · DK
Project2: Impact of adipose-tissue derived FGF21 on immunometabolic control of aging
$551,948Philipp E Scherer · Yale University · P01 · FY2023 · AG
Project 1 - Dixit
$551,948Vishwa Deep Dixit · Yale University · P01 · FY2023 · AG
Toxic lipid intermediate accumulation and cobalamin depletion promote AHR-mediated hepatotoxicity and the progression of non-alcoholic fatty liver disease (NAFLD)-like pathologies
$551,938Timothy R Zacharewski · Michigan State University · R01 · FY2025 · ES
RECK regulation of NASH and fibrosis
$551,909Randy Scott Rector · University Of Missouri-Columbia · R01 · FY2023 · DK
RECK regulation of NASH and fibrosis
$551,909Randy Scott Rector · University Of Missouri-Columbia · R01 · FY2025 · DK
RECK regulation of NASH and fibrosis
$551,909Randy Scott Rector · University Of Missouri-Columbia · R01 · FY2022 · DK
Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis
$551,891Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Project 3: Non-invasive assessment of liver fibrosis stage and progression in obesity and diabetes: a Hispanic population study
$551,862Laura Beretta · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Neurodevelopmental and neurodegenerative effects of environmental determinants: altering neural cellular populations impacting homeostatic functions and inflammatory response.
$551,850Nicholas Francis Fitz · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AG
Neurodevelopmental and neurodegenerative effects of environmental determinants: altering neural cellular populations impacting homeostatic functions and inflammatory response.
$551,850Nicholas Francis Fitz · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AG
CTRP and Metabolic Control
$551,838Guang William Wong · Johns Hopkins University · R01 · FY2021 · DK
CTRP and Metabolic Control
$551,838Guang William Wong · Johns Hopkins University · R01 · FY2022 · DK
CTRP and Metabolic Control
$551,838Guang William Wong · Johns Hopkins University · R01 · FY2020 · DK
CTRP and Metabolic Control
$551,838Guang William Wong · Johns Hopkins University · R01 · FY2023 · DK
The role of cannabinoid 1 receptor in age-associated diseases
$551,696Yoo Kim · Oklahoma State University Stillwater · R15 · FY2025 · DK
Improving Liver Ultrasound Image Quality in Difficult-to-Image Patients
$551,305Jeremy Dahl · Stanford University · R01 · FY2022 · EB
Pivotal Role of Oxidation-specific Epitopes in CVD and NASH
$551,250Joseph L Witztum · University Of California, San Diego · R01 · FY2019 · HL
Combination of ceramide and immunotherapy in treatment of hepatocellular cancer
$551,141Kevin Finnbar Staveleyo'carroll · University Of Missouri-Columbia · R01 · FY2019 · CA